Gynecologic Oncology is the Society of Gynecologic Oncology's journal for ovarian, endometrial, cervical and vulvar cancer research, surgery and PARP-inhibitor and immunotherapy trials.
Gynecologic Oncology (Gynecol Oncol) is the journal of the Society of Gynecologic Oncology (SGO), founded in 1972 and published monthly by Elsevier on a hybrid access model. It covers ovarian, endometrial, cervical and vulvar cancer research, surgery, and PARP-inhibitor and immunotherapy trials, publishing phase 2 trials, surgical outcome studies, HPV and cervical screening research and SGO clinical practice statements, with the SGO annual meeting abstracts as a supplement. Its readers are gynaecological oncologists and the surgeons and trialists working alongside them. Within OnCo it is linked from the Society of Gynecologic Oncology and GOG Foundation entries, and it is where a reader would look for society statements and gynaecological trial results.
Oslo gynaecological oncology surgeon at the Norwegian Radium Hospital and President-Elect of ESGO.
Chief physician who directs Tays Cancer Centre in Tampere and the FICAN Mid regional cancer centre for central Finland.
Professor who chairs the executive board of University Medical Center Groningen, the academic hospital in the northern Netherlands that houses the UMCG Comprehensive Cancer Center.
Blood cancer specialist who leads the Juravinski Cancer Centre, one of Ontario's largest integrated cancer programmes, as Vice President of Oncology.
Professor who runs the Centre Antoine Lacassagne, the regional cancer centre in Nice, as its Directeur Général.
Gynecologic oncologist and endometrial cancer trialist who is President of the Society of Gynecologic Oncology.
Physician-in-Chief and Executive Director of the Northwell Cancer Institute, the cancer service of New York's largest health system.
Oklahoma gynecologic oncologist and Senior Vice President of the GOG Foundation.
Cincinnati gynecologic oncologist who has led the GOG Foundation as President since July 2023.